Evidence map›Paper›PMID 22192732›Full record

ArticleToxicon : official journal of the International Society on Toxinology2012

Recombinant rubistatin (r-Rub), an MVD disintegrin, inhibits cell migration and proliferation, and is a strong apoptotic inducer of the human melanoma cell line SK-Mel-28.

Clayton M Carey, Raymund Bueno, Daniel A Gutierrez, Christopher Petro, Sara E Lucena, Elda E Sanchez, Julio G Soto

Open access · greenAbstract read
In one paragraph

Article in Toxicon : official journal of the International Society on Toxinology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
0.6field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it, 29 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Clayton M CareyBiological Sciences Department, San José State University, One Washington Square, DH 254, San José, CA 95192-0100, USA.
Raymund Bueno
Daniel A Gutierrez
Christopher Petro
Sara E Lucena
Elda E Sanchez
Julio G Soto
San Jose State University · USTexas A&M University – Kingsville · US

Funding

San Jose State University Undergraduate MBRS RISE ProgramR25GM071381 · NIGMS · SAN JOSE STATE UNIVERSITY · PI SINGMASTER, KAREN A · 2008 to 2021
$6.3M
YEAST CHROMATIN STRUCTURE: RECONSTITUTION EXPERIMENTSS06GM008192 · NIGMS · SAN JOSE STATE UNIVERSITY · PI SILBER, HERBERT BRUCE · 1989 to 2009
$6.3M
Viper Resource Center (VRC) at Texas A&M University-KingsvilleP40RR018300 · NCRR · TEXAS A&M UNIVERSITY-KINGSVILLE · PI PEREZ, JOHN CARLOS · 2003 to 2011
$4.5M
NCRR NIH HHS 2P40RR018300NCRR NIH HHS P40 RR018300NIGMS NIH HHS 2S06 GM008192NIGMS NIH HHS R25 GM071381NIGMS NIH HHS R25GM071381NIGMS NIH HHS S06 GM008192
6 · The paper itself

Abstract

Disintegrins are low molecular weight peptides isolated from viper venom. These peptides bind to integrin receptors using a conserved binding motif sequence containing an RGD or similar motif. As a consequence, disintegrins can inhibit platelet aggregation and inhibit cell migration, proliferation, and initiate apoptosis in cancer cell lines. Rubistatin is a MVD disintegrin cloned from a Crotalus ruber ruber venom gland. The biological activity of MVD disintegrins is poorly understood. Recombinant rubistatin (r-Rub) was cloned into a pET32b plasmid and expressed in reductase-deficient Escherichia coli. Expression was induced with IPTG and the resulting fusion peptide was affinity purified, followed by thrombin cleavage, and removal of vector coded sequences. r-Rub peptide inhibited ADP-induced platelet aggregation by 54% ± 6.38 in whole blood. We assessed the ability of r-Rub to initiate apoptosis in three human cancer cell lines. Cultures of SK-Mel-28, HeLA, and T24 cells were grown for 24 h with 2.5 μM r-Rub followed by Hoechst staining. Chromatin fragmentation was observed in treated SK-Mel-28, but not in T24 or HeLA cells. A TUNEL assay revealed that 51.55% ± 5.28 of SK-Mel-28 cells were apoptotic after 18 h of treatment with 3.5 μM of r-Rub. Cell migration and proliferation assays were performed in order to further characterize the biological effects of r-Rub on SK-Mel-28 cells. At 3 μM, r-Rub inhibited cell migration by 44.4% ± 0.5, while at 3.5 μM it was able to inhibit cell proliferation by 83% ± 6.0.

Indexed as

Amino Acid SequenceAnimalsApoptosisBase SequenceCell Line, TumorCell MovementCell ProliferationCloning, MolecularCrotalid VenomsCrotalusDisintegrinsGene Expression RegulationHeLa CellsHumansMolecular Sequence DataOligopeptidesarginyl-glycyl-aspartic acidCrotalid VenomsDisintegrinsOligopeptidesRecombinant Proteins

Identifiers

PMID22192732
PMCPMC3282178
OpenAlexW2064201178

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.